Vir Biotechnology Inc.
VIR | NASDAQ
$10.88
+$0.28 (+2.64%)
At close: Sep 21, 2026, 4:00 PM ET
$11.31
+$0.43 (+3.95%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.91 | -1.92 | -2.19 | 6.51 | 10.29 | -10.67 |
PEG Ratio | 0.11 | 0.12 | 0.01 | -1.47 | -0.04 | -0.19 |
PS Ratio | 12.18 | 13.48 | 15.66 | 2.08 | 4.96 | 47.45 |
PB Ratio | 1.09 | 0.87 | 0.85 | 1.62 | 3.80 | 4.45 |
P/FCF Ratio | -2.11 | -2.20 | -1.69 | 2.10 | -78.35 | -16.16 |
P/OCF Ratio | -2.13 | -2.24 | -1.73 | 2.02 | -114.28 | -16.71 |
OCF/S Ratio | -571.48 | -601.51 | -903.67 | 102.94 | -4.34 | -283.95 |
Debt / Equity Ratio | 0.24 | 0.09 | 0.08 | 0.06 | 0.10 | 0.10 |
Quick Ratio | 5.54 | 8.71 | 9.05 | 4.93 | 4.58 | 7.80 |
Current Ratio | 5.54 | 8.71 | 9.05 | 4.93 | 4.58 | 7.80 |
Asset Turnover | 0.07 | 0.05 | 0.04 | 0.58 | 0.56 | 0.07 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -57.23% | -45.37% | -38.68% | 24.82% | 36.92% | -41.66% |
Return on Assets | -43.68% | -37.31% | -32.05% | 18.41% | 27.05% | -32.51% |
Return on Invested Capital | -50.94% | -45.53% | -38.15% | 24.82% | 25.02% | -36.07% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 82.92% | -545.03% | -564.69% | 61.57% | 53.09% | 100% |
Net Profit Margin | -638.87% | -703.40% | -713.69% | 31.92% | 48.25% | -444.14% |
Pretax Profit Margin | -638.56% | -704.95% | -728.93% | 46.68% | 50.19% | -444.06% |
Operating Profit Margin | -682.68% | -791.27% | -794.04% | 51.56% | 38.41% | -441.64% |
FCF Margin | -578.52% | -611.35% | -928.71% | 98.73% | -6.34% | -293.69% |
EBITDA Margin | -621.52% | -685.82% | -744.53% | 47.10% | 50.72% | -433.55% |
Add to Watchlist
Select watchlists to add or remove VIR